@harryarien's TRT adaptation claims, fact-checked

A TikTok from @harryarien about testosterone adaptation has racked up 1.7 million views with a simple message: his body took time to adjust to TRT, but persistence paid off. The video's in Spanish and tagged with trans-related hashtags, suggesting this is about gender-affirming hormone therapy.

What does this video actually claim?

The creator states his body needed time to adapt to treatment, but everything worked out with perseverance. That's pretty much it. No specific timelines, dosages, or detailed effects mentioned.

This matches what we see in most successful TRT patient stories. The message is reassuring rather than medically specific. He's sharing his experience without making clinical claims about what others should expect.

The brevity actually works in his favor from a medical accuracy standpoint. He's not overselling quick fixes or making promises about specific outcomes.

Does the science back up adaptation challenges?

Yes, testosterone therapy typically involves a months-long adjustment period with variable responses between patients. The TRAVERSE trial (Lincoff et al., NEJM, 2023) tracked 5,246 men and found symptom improvements often took 3-6 months to stabilize.

For transgender men specifically, the Endocrine Society guidelines note that physical changes from testosterone can take 1-5 years to fully develop. Voice changes might start at 3-6 months, while muscle mass changes continue for years.

Starting doses are deliberately conservative. Most protocols begin with 50-100mg testosterone cypionate weekly, then adjust based on blood levels and symptom response. This gradual approach explains why adaptation takes time.

What about the perseverance message?

This part gets tricky because it oversimplifies what "persistence" means in hormone therapy. Successful TRT isn't just about toughing it out through side effects.

Real persistence means regular blood monitoring, dose adjustments, and working with healthcare providers to optimize treatment. The TRAVERSE study required testosterone levels between 350-750 ng/dL, which took multiple dose adjustments for many participants.

Some adaptation challenges signal problems that need medical attention, not just patience. Severe mood changes, cardiovascular symptoms, or persistent fatigue warrant dose modifications or alternative approaches.

What's missing from this narrative?

The video skips the medical monitoring that makes TRT safe and effective. Testosterone therapy requires baseline blood work, then follow-up labs at 3 months, 6 months, and annually thereafter.

Key markers include total and free testosterone, estradiol, hematocrit, and lipid panels. The American Urological Association guidelines specify target testosterone levels of 450-600 ng/dL for most patients.

He also doesn't mention potential side effects that require attention. These include sleep apnea, elevated red blood cell counts, and cardiovascular risks, particularly in older patients.

Should you follow this advice?

The core message about patience during hormone therapy is sound, but it's incomplete without emphasizing medical supervision. TRT adaptation is normal, but it's not a DIY process.

If you're considering testosterone therapy, whether for hypogonadism or gender-affirming care, work with providers experienced in hormone management. They'll help distinguish normal adaptation from concerning side effects.

The video's positive tone is actually valuable. Many patients discontinue TRT prematurely because early effects don't match their expectations. Understanding that benefits develop gradually can improve treatment adherence.